Nerve growth factor for the treatment of diabetic neuropathy: What went wrong, what went right, and what does the future hold?

This publication has 38 references indexed in Scilit:

• Topical treatment with nerve growth factor for neurotrophic keratitis
  Ophthalmology, 2000
• Human Recombinant Nerve Growth Factor Replaces Deficient Neurotrophic Support in the Diabetic Rat
  European Journal of Neuroscience, 1995
• Nerve growth factor prevents neurotoxic effects of cisplatin, vincristine and taxol, on adult rat sympathetic ganglion explants in vitro
  Life Sciences, 1994
• Axonal Transport of Endogenous Nerve Growth Factor (NGF) and NGF Receptor in Experimental Diabetic Neuropathy
  Experimental Neurology, 1994
• The effect of systemically administered recombinant human nerve growth factor in healthy human subjects
  Annals of Neurology, 1994
• Nerve growth factor prevents experimental cisplatin neuropathy
  Annals of Neurology, 1992
• trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3
  Cell, 1991
• The trk proto-oncogene encodes a receptor for nerve growth factor
  Cell, 1991
• A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
  Pain, 1988
• Destruction of the sympathetic nervous system in neonatal rats and hamsters by vinblastine: prevention by concomitant administration of nerve growth factor
  Brain Research, 1978